ArticleFEBS open bio2024
Correction.
Article in FEBS open bio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
0 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
correctionRETRACTION: Wogonoside Promotes Apoptosis in Gastric Cancer AGS and SGC-7901 Cells Through Induction of Mitochondrial Dysfunction and Endoplasmic Reticulum Stress X.M. Hu, J.J. Xiang, B.L. Xiao, Y.F. Huang, and J.P. Xie, "Retraction statement: Hu X-M, Xiang J-J, Xiao B-L, Huang Y-F and Xie J-P (2019) Wogonoside promotes apoptosis in gastric cancer AGS and SGC-7901 cells through induction of mitochondrial dysfunction and endoplasmic reticulum stress," FEBS Open Bio, no. 13 (2023): 796, https://doi.org/10.1002/2211-5463.13584. Information regarding the coauthor Ying-Fei Huang's non-involvement with the research and writing of this article was erroneously missed in the above retraction notice and has been included in this version. The corrected retraction notice is: The above article, published online on 28 June 2019 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the Editor-in-Chief, FEBS Press, and John Wiley and Sons Ltd. The retraction has been agreed following an investigation into concerns raised by a third party, which revealed inappropriate duplications between this and previously published articles [[1, 2]]. Thus, the editors consider the conclusions of this manuscript substantially compromised. Additionally, the coauthor Ying-Fei Huang's institution University of New South Wales informed the journal that Ms. Huang was not involved with the research or writing of this article, and that her name and affiliation were used without her knowledge or permission. References 1 Sun L, Jiang C, Xu C, Xue H, Zhou H, Gu L, Liu Y and Xu Q (2017) Down-regulation of long non-coding RNA RP11-708H21.4 is associated with poor prognosis for colorectal cancer and promotes tumorigenesis through regulating AKT/mTOR pathway. Oncotarget 8, 27929-27942. 2 Li Y, Tao C, Dai L, Cui C, Chen C, Wu H, Wei Q and Zhou X (2019) MicroRNA-625 inhibits cell invasion and epithelial-mesenchymal transition by targeting SOX4 in laryngeal squamous cell carcinoma. Biosci Rep 39, BSR20181882.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.